Status:
RECRUITING
A Multicentre Study of Wastewater and Antibiotic Resistance in Care Homes.
Lead Sponsor:
Nantes University Hospital
Conditions:
Antimicrobial Resistance
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to model the relationship between the prevalence of ESBL-E and CPE carriage among nursing home residents and their respective concentrations in wastewater discharged from the facility.
Detailed Description
Extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) are now endemic in France, complicating the management of infections. In parallel, carbapenemase-producing Enterobacterales (CPE) ...
Eligibility Criteria
Inclusion Criteria:
- Residents present on the day of sampling (D0 or D+1) in a facility selected during randomization, without criteria regarding length of stay in the facility, and whose health status on the day of the survey permits it;
- Residents who, based on clinical criteria (including an MMSE greater than or equal to 20), are deemed by the nursing home team to be able to understand the issues of the study and to express an informed non-opposition; OR Residents who the nursing home team considers unable to express an informed non-objection but who have a legal representative, a trusted person, or a loved one capable of understanding the information and expressing an informed non-objection.
Residents may be included regardless of the presence of infection, diarrheal stools, antibiotic use or any other treatment, or health status.
Participants in this study may participate in other research projects concurrently.
Exclusion Criteria: Health and medico-social facilities not considered nursing homes (e.g., FAM, MAS, etc.);
- Residents whose health status is incompatible with performing the procedure on the day of the survey (e.g., end-of-life with comfort care);
- Residents with a Mini Mental State Examination (MMSE) score of less than or equal to 20, or without an MMSE score but who, according to nursing home professionals, are unable to provide an informed non-objection and who do not have a legal representative, trusted person, or relative capable of receiving information and providing an informed non-objection;
- Residents, regardless of their MMSE score, who refuse to have the sample taken on the day of the survey even if their legal repre
Key Trial Info
Start Date :
March 16 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT07234331
Start Date
March 16 2026
End Date
June 30 2027
Last Update
April 16 2026
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU d'Angers
Angers, France, 49100
2
CHU de Nantes
Nantes, France, 44093